All News

2020

July

Media Release / Jul 27, 2020

Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

Read More
Media Release / Jul 21, 2020

Novartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales.

Read More
Media Release / Jul 13, 2020

Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering

Read More
Media Release / Jul 07, 2020

Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals

Read More
Media Release / Jul 01, 2020

Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case

Read More

June

Media Release / Jun 19, 2020

Novartis discontinues hydroxychloroquine clinical trial based on slow enrollment, remains committed to pandemic research efforts

Read More

April

Media Release / Apr 28, 2020

Novartis maintains strong operational performance in Q1, confirms FY 2020 guidance at this time, and advances a broad range of efforts to support the global response to COVID-19

Read More
Media Release / Apr 20, 2020

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients

Read More
Media Release / Apr 02, 2020

Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo

Read More

March

Media Release / Mar 30, 2020

Novartis donation: Consignment of 30 million hydroxychloroquine tablets ships to US Department of Health and Human Services

Read More